Just as relatively high disorder levels in the M protein (PID: 28%, 29%) are a hallmark of the ZIKV, an effective vaccine needs to have an M protein with a lower PID so that an attenuated virus will not penetrate the placenta of pregnant women. This evidence concerns the gene MYOM2 and pelvic inflammatory disease.